Terumo Aortic Announces Launch of the Global Thoraflex Hybrid EXTEND Study

June 13, 2023

Medical

RENFREW, Scotland – June 13, 2023 – Terumo Aortic, a division of Terumo Corporation, today announced the launch of the global Thoraflex™ Hybrid EXTEND Study, a post-market clinical study designed to further evaluate long-term outcomes associated with the Thoraflex Hybrid device.

The EXTEND Study will collect long-term clinical data across multiple international sites to build on the existing body of evidence supporting the Thoraflex Hybrid device's use in the treatment of complex aortic arch disease.

"The EXTEND Study reflects our ongoing commitment to generating robust, long-term clinical evidence for the Thoraflex Hybrid device," said a Terumo Aortic representative. "This study will help us continue to support surgeons and patients with confidence in this important treatment option."

The study is expected to enroll patients across multiple centers globally, further strengthening the clinical foundation for the Thoraflex Hybrid device in the treatment of complex aortic disease.

About Terumo India

Terumo India is a fast-growing medical devices company that serves to advance access to high-quality Cardiac & Vascular, and other medical devices for patients and medical practitioners in India. Terumo India is part of Terumo Corporation, a global leader in medical technology with headquarters in Tokyo, Japan. Established in 1921 and with its 100 years of history, Terumo's starting point and unchanging corporate mission has been 'Contributing to Society through Healthcare'.

Terumo India was established in 2013 with headquarters in Gurgaon, NCR Delhi and has since grown to touch over 100,000 lives with an expanding field force & distribution network. Terumo India is Great Place to Work® certified and has also been recognized as one of India's Top 15 Workplaces™ in Pharmaceuticals, Healthcare and Biotech 2022. The company runs several acclaimed training & development programs, working closely with its customers and academic partners to contribute to the skilling requirements of India's healthcare system.

Media Contact

Terumo India Private Limited

About Terumo

Terumo (TSE: 4543) is a global medical innovation company. Guided by an unwavering commitment to patients, and driven by the passion of our associates, we strive to fulfill our Group Mission of "Contributing to Society through Healthcare." Founded in Tokyo in 1921, we provide a comprehensive range of solutions in the fields of therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.

Media Contact

Corporate Communication Dept., Terumo Corporation

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.